BARRIER THERAPEUTICS INC 4
4 · BARRIER THERAPEUTICS INC · Filed Aug 6, 2008
Insider Transaction Report
Form 4
CAUWENBERGH GEERT
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2008-08-06−2,970→ 0 totalExercise: $3.50Exp: 2014-01-19→ Common Stock (2,970 underlying) - Disposition to Issuer
Stock Option (right to buy)
2008-08-06−85,000→ 0 totalExercise: $3.35Exp: 2018-03-14→ Common Stock (85,000 underlying) - Disposition from Tender
Common Stock
2008-08-05$4.15/sh−635,613$2,637,794→ 0 total
Footnotes (2)
- [F1]Includes 101,776 shares of restricted stock which became vested pursuant to the Agreement and Plan of Merger dated June 23, 2008 between Barrier Therapeutics, Inc., Stiefel Laboratories, Inc. and Bengal Acquisition Inc. (the "Merger"). Also includes 11,000 shares held indirectly by Dr. Cauwenbergh for his wife, son and daughter.
- [F2]This option was canceled in connection with the Merger in exchange for the right to receive the difference between the merger consideration of $4.15 per share and the option exercise price.